Marinus Pharmaceuticals | SC 13G:超过5%持股股东披露文件-Citadel Securities LLC(0.4%),Citadel Securities Group LP(0.4%)等
04/26 05:56
Marinus Pharmaceuticals | SC 13G:超过5%持股股东披露文件-TANG CAPITAL PARTNERS, LP(8.2%),Tang Capital Management, LLC(8.2%)等
04/19 18:12
Marinus Pharmaceuticals | 8-K:Marinus Pharmicals提供第三阶段RAISE试验的最新情况,并公布了2024年第一季度的初步财务业绩
04/15 19:33
Marinus Pharmaceuticals | DEFA14A:其他
04/04 20:05
Marinus Pharmaceuticals | DEF 14A:股东委托书决议
04/04 20:05
Marinus Pharmaceuticals | 8-K:重大事件
03/28 04:12
Marinus Pharmaceuticals | 4:持股变动声明-高管 Braunstein Scott
03/27 23:59
Marinus Pharmaceuticals | 10-K:年度报表
03/06 05:19
Marinus Pharmaceuticals | 8-K:Marinus Pharmicals提供最新业务并报告2023年第四季度和全年财务业绩
03/06 05:10
Marinus Pharmaceuticals | 4:持股变动声明-高管 MANNING MARTHA E
02/23 05:08
Marinus Pharmaceuticals | 4:持股变动声明-高管 Shafer Christina
02/23 05:08
Marinus Pharmaceuticals | 4:持股变动声明-高管 Hulihan Joseph
02/22 05:12
Marinus Pharmaceuticals | 4:持股变动声明-高管 Pfanstiel Steven
02/22 05:10
Marinus Pharmaceuticals | 4:持股变动声明-高管 Braunstein Scott
02/22 05:09
Marinus Pharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-LION POINT CAPITAL, LP(3.9%),LION POINT HOLDINGS GP, LLC(3.9%)等
02/15 06:41
Marinus Pharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-Cormorant Global Healthcare Master Fund, LP(5.96%),Cormorant Global Healthcare GP, LLC(5.96%)等
02/15 04:13
Marinus Pharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-Eventide Asset Management, LLC(8.30%),Finny Kuruvilla, M.D. Ph. D.(8.30%)等
02/15 01:22
Marinus Pharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-Point72 Asset Management, L.P.(0.9%),Point72 Capital Advisors, Inc.(0.9%)等
02/14 23:14
Marinus Pharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-Avoro Capital Advisors LLC(5.8%),Behzad Aghazadeh(5.8%)
02/14 22:07
Marinus Pharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-Suvretta Capital Management, LLC(9.99%),Aaron Cowen(9.99%)等
02/14 01:15
暂无数据
暂无数据